Subscribe

Finra bars ex-Deutsche Bank broker for manipulating stock price

Edward Brokaw, a former Deutsche Bank AG broker, was barred from the securities industry for manipulating the price of Monogram Biosciences stock in an effort to enrich a hedge-fund client, himself and his family, the Financial Industry Regulatory Authority said today.

Edward Brokaw, a former Deutsche Bank AG broker, was barred from the securities industry for manipulating the price of Monogram Biosciences stock in an effort to enrich a hedge-fund client, himself and his family, the Financial Industry Regulatory Authority said today.

Finra announced a hearing panel’s ruling against Brokaw, who worked for Deutsche Bank Securities in its Greenwich, Connecticut branch, in an e-mail release today.

Learn more about reprints and licensing for this article.

Recent Articles by Author

Bank of America sounds warning on options-ETF boom

Skeptics says products often fare worse than simpler alternatives.

Gold in flux as investors await Fed meeting

Following a 13 percent advance this year, the price of the yellow metal wavered as traders weigh the odds of harmful rate hikes.

Hedge funds ramp up tech allocations, says Goldman

Data show amped-up net buying in sector through long positions and short-covering even amid a slide in S&P 500 IT index.

Stocks rise following hot March inflation

The S&P 500 is poised to extend gains on tech earnings while short-term Treasury yields fell following brisk rise in Fed’s preferred inflation gauge.

Fed will cut once before presidential election, says Howard Lutnick

Cantor Fitzgerald’s chief executive predicts the central bank will “show off a little bit” just before voters head to the polls.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print